Editor of Patient Care Online.
Daily Dose: Opioid Use for Low Back Pain and Neck Pain
Your daily dose of clinical news you may have missed.
More Adolescents Worldwide Experience Body Weight Misperceptions, According to New Study
Underestimation of weight status increased while overestimation decreased during the last 2 decades, according to results from a study of over 745 000 adolescents.
Daily Dose: Association of Population Wellbeing with Cardiovascular Outcomes
Expert to Primary Care: Use these "ABCs" to Manage Obesity and T2D
The importance of avoiding judgement, monitoring behavior, and cardiovascular risk prevention in primary care are discussed, here.
Daily Dose: Vitamin D Supplementation and Major Cardiovascular Events in Older Adults
Statins Appear Beneficial for CV Outcomes in Primary Prevention Patients with HTN without CVD or Diabetes
In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.
Daily Dose: Loneliness and CVD Risk in Patients with Diabetes
Frequent Opioid Use for Low Back Pain, Neck Pain Called into Question in New Study
Results showed that the use of opioid analgesics did not confer any benefits for adults with acute low back pain or neck pain compared to placebo.
Daily Dose: Childhood Glycemic Measures as Predictors of Diabetes-Related Complications
Treating Obesity & T2D: Experts Say Simultaneous, Early Intervention is Key
Early intervention is crucial to help prevent complications in patients with obesity and type 2 diabetes. Two experts explain more, here.
Monthly Vitamin D Supplementation May Lower the Risk of Major CV Events in Older Adults
Vitamin D supplementation may reduce the incidence of major cardiovascular events in older adults, suggests new research.
Daily Dose: Pegozafermin in Patients with NASH
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Daily Dose: High-Dose Oral Semaglutide May be Beneficial for T2D Management
Glycemic Screening in Childhood May Predict Diabetes-Related Complications, According to New Data
ADA 2023: Findings from a new study show that higher levels of glycemia in childhood are associated with future microvascular complications, such as nephropathy and retinopathy.
Daily Dose: HF, CV Benefit of SGLT-2 Inhibition Consistent in T2D, CDK, HF
Health Inequities in Persons with Obesity & Type 2 Diabetes Exacerbated During COVID-19 Pandemic
Listen to 2 obesity experts discuss the impact of the COVID-19 pandemic on obesity-related type 2 diabetes.
Daily Dose: Bempedoic Acid Reduces Risk for MACE in Primary Prevention Population
New Data Suggest Higher Doses of Oral Semaglutide Beneficial for Management of Type 2 Diabetes
ADA 2023. Results from PIONEER PLUS trial showed oral semaglutide 25 mg and 50 mg were superior than 14 mg in reducing HbA1c and body weight in adults with T2D.
Daily Dose: Novel Drug Therapy for Obesity Shown Effective Up to 46 Weeks
Oral Semaglutide 50 mg May be Effective Option for Obesity Treatment, According to OASIS 1 Study Authors
ADA 2023. Once-daily oral semaglutide 50 mg induced 15.1% weight loss in adults with overweight or obesity without type 2 diabetes vs placebo.
Daily Dose: Tirzepatide Leads to 15% Weight Loss in Adults with Obesity, T2D
Obesity & Type 2 Diabetes: Early Intervention Critical in Reducing Risk for Complications
Early intervention is important to reduce the risk for complications for patients with obesity and type 2 diabetes. Two obesity experts explain more, here.
Daily Dose: Healthy Lifestyle & Risk of CVD Among Postmenopausal Women With Normal BMI
Daily Dose: Cardiovascular Safety of Testosterone-Replacement Therapy in Men with Hypogonadism
Obesity and Type 2 Diabetes: Experts Analyze the Role of Insulin Resistance
Listen to 2 obesity experts discuss and analyze the role of insulin resistance in type 2 diabetes and obesity.
Daily Dose: PCOS Associated with Higher Mortality Risk
Polycystic Ovary Syndrome Associated with Higher Mortality Risk, According to New Research
ENDO 2023. Women with PCOS face an increased risk of mortality, particularly death due to cardiovascular disease and diabetes, compared with those without PCOS.
Daily Dose: Bempedoic Acid Found Comparable to Statins for Lowering LDL-C
Daily Dose: Postmenopausal Women Using Oral Estrogen Hormone Therapy More Likely to Develop HTN